GlassScriptPhysician profile
Matthew S Cummings
NPI 1497953848
$4,540.72
in general payments reported to CMS, 2019-2025
32 companies · $746 in 2025
The $746 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2020: $184 · 2021: $375 · 2022: $1,088 · 2023: $999 · 2024: $587 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,331.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $787.82 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $553.95 | 2019-2024 | Brilinta, Wainua, Farxiga |
| Abbott Laboratories | $462.40 | 2023-2025 | Amplatzer Talisman, Mitraclip, Xience Skypoint |
| E.R. Squibb & Sons, L.L.C. | $401.66 | 2021-2025 | Camzyos, Eliquis |
| Amgen INC. | $316.15 | 2019-2025 | Repatha, Repatha |
| Abiomed | $315.73 | 2020-2025 | Impella |
| Boston Scientific Corporation | $244.66 | 2019-2024 | Ekosonic, Watchman Access System, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.73 | 2019-2025 | Lifevest |
| Heartflow, INC. | $183.35 | 2025 | |
| Pfizer INC. | $133.77 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $125.06 | 2020-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $115.10 | 2022-2023 | |
| Cardiva Medical, INC. | $94.27 | 2021-2024 | Savvywire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.41 | 2022-2025 | Jardiance |
| Bard Peripheral Vascular, INC. | $67.06 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $66.87 | 2021-2024 | Ozempic, Rybelsus |
| Medtronic Vascular, INC. | $35.22 | 2019 | |
| Esperion Therapeutics, INC. | $33.08 | 2021 | |
| Chiesi USA, INC. | $29.66 | 2019-2024 | Kengreal |
| Medtronic, INC. | $29.63 | 2021-2022 | |
| Gilead Sciences, INC. | $26.65 | 2019 | |
| Siemens Medical Solutions USA, INC. | $24.00 | 2023 | Artis Zee Multi-Purpose |
| Biosense Webster, INC. | $21.83 | 2025 | Smartablatetm System Rf Generator |
| Vital Connect, INC | $20.82 | 2023 | Vitalpatch Rtm |
| Inari Medical, INC. | $19.78 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Convatec INC. | $17.88 | 2022 | |
| Alnylam Pharmaceuticals INC. | $16.04 | 2025 | Onpattro |
| Bridgebio Pharma, INC. | $15.81 | 2025 | Attruby |
| Terumo Medical Corporation | $15.18 | 2023 | Glidewire |
| Bardy Diagnostics, INC. | $15.00 | 2020 | |
| Merck Sharp & Dohme LLC | $14.49 | 2021 | |
| Shockwave Medical, INC | $13.66 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Cummings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.